Research News

A new protein as a target for cancer treatment

Any disruption in RNA processing by RNA binding proteins (RBPs) may lead to cancers. This research article published by Natures Communications and helmed by Associate Professor Polly Chen provides insights into the role of a cancer associated protein, DAP3, in cancer development. Findings in this research article suggests that targeting or blocking the protein DAP3 may hold great promise for cancer treatment.

Read more: https://www.nature.com/articles/s41467-022-29400-7#article-info

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →
Research News

DriverDetect Software: Enhancing Cancer Mutation Prediction with Machine Learning

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction tools vary in accuracy. N2CR member A/Prof …

Read More →
Research News

Understanding RNA Changes and Cancer Development

Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP3) in …

Read More →